BackgroundCheck.run
Search For

Keith E Flaherty, 385 Franklin Springs Rd, Franklin, MA 02038

Keith Flaherty Phones & Addresses

5 Franklin Springs Rd, Franklin, MA 02038   

130 Turner St, Quincy, MA 02169    617-7702259   

Randolph, MA   

6 Morgan St, Randolph, MA 02368   

Work

Address: 55 Fruit St, Boston, MA 02114 Specialities: Internist

Education

School / High School: Doctor of Medicine

Ranks

Certificate: American Board of Internal Medicine Sub-certificate in Oncology (Internal Medicine)

Mentions for Keith E Flaherty

Career records & work history

Medicine Doctors

Keith T. Flaherty

Specialties:
Medical Oncology
Work:
Massachusetts General Hospital Cancer Center
32 Fruit St FL 7-9, Boston, MA 02114
617-7244000 (phone) 617-7261949 (fax)
Education:
Medical School
Johns Hopkins University School of Medicine
Graduated: 1997
Procedures:
Chemotherapy
Conditions:
Gastric Cancer, Melanoma, Pancreatic Cancer
Languages:
English, Spanish
Description:
Dr. Flaherty graduated from the Johns Hopkins University School of Medicine in 1997. He works in Boston, MA and specializes in Medical Oncology. Dr. Flaherty is affiliated with Massachusetts General Hospital.
Keith Flaherty Photo 1

Keith T Flaherty

Specialties:
Dermatology
Internal Medicine
Hematology & Oncology
Hematology
Medical Oncology
Hematology
Education:
Johns Hopkins University (1997)
Keith Flaherty Photo 2

Keith Flaherty, Boston MA

Specialties:
Internist
Address:
55 Fruit St, Boston, MA 02114
Education:
Doctor of Medicine
Hospital of the University of Pennsylvania - Fellowship - Hematology and Oncology (Internal Medicine)
Brigham & Women's Hospital - Residency - Internal Medicine
Board certifications:
American Board of Internal Medicine Sub-certificate in Oncology (Internal Medicine)

Keith Flaherty resumes & CV records

Resumes

Keith Flaherty Photo 38

Keith Flaherty

Keith Flaherty Photo 39

Keith Flaherty

Skills:
Microsoft Word
Keith Flaherty Photo 40

Keith Flaherty

Keith Flaherty Photo 41

Keith Flaherty

Publications & IP owners

Us Patents

Dosing Regimens For Treatment Of Solid Tumors Having One Or More Genetic Alterations In Fgfr1, Fgfr2, And/Or Fgfr3

US Patent:
2021020, Jul 8, 2021
Filed:
May 15, 2019
Appl. No.:
17/055886
Inventors:
- Lausanne, CH
Keith T. FLAHERTY - Cambridge MA, US
Hiroaki TANAKA - Lausanne, CH
Anna POKORSKA-BOCCI - Denens, CH
Franck BRICHORY - Bonne, CH
International Classification:
A61K 31/4184
A61K 9/20
A61P 35/00
Abstract:
Methods of administering Compound A, or pharmaceutically acceptable salt thereof, for the treatment of solid tumors having one or more genetic alterations in FGFR1, FGFR2 and/or FGFR3 are provided.

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.